Research on Diffuse Hair Loss in Unani Medicine
- Conditions
- Health Condition 1: L659- Nonscarring hair loss, unspecified
- Registration Number
- CTRI/2023/11/060235
- Lead Sponsor
- Government Unani Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Clinically diagnosed patients of DHL.
Female patients of 18-50 years age.
Patients with Hair Shedding Score greater than or equal to 5.
Cases of DHL associated with stress of any kind such as postpartum, postoperative or post febrile, deficiency states such as iron deficiency and protein malnutrition.
Patients who have agreed to sign the informed consent form and follow up during the protocol.
Female patients less than 18 yrs of age and greater than 50 yrs.
Patients suffering from other scalp diseases like scalp psoriasis, seborrhoeic dermatitis, tinea capitis, alopecia areata, scarring alopecia, congenital alopecia, alopecia totalis, alopecia universalis and trichotillomania.
Patients on systemic drugs like anticoagulants, immunosuppressants, and antithyroid drugs.
Pregnant, lactating or postmenopausal women.
Known cases of hypothyroidism.
Patients on chemotherapy and radiotherapy.
History of any treatment for hair loss within previous one month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in Hair Shedding Score.Timepoint: 0th day, 15th day, 30th day and 45th day
- Secondary Outcome Measures
Name Time Method Decrease in Score of Dermatology Life Quality Index (DLQI) Questionare. <br/ ><br>Changes in Photography of the Scalp. <br/ ><br>Timepoint: 0th day, 15th day, 30th day and 45th day